Characteristics of Children Referred to a Lipid Clinic Before and After the Universal Screening Guidelines

Kavitha Selvaraj*, Alicia Olave-Pichon, Irwin Benuck, Adolfo Javier Ariza, Helen Binns

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

In 2011, universal lipid screening was recommended for children aged 9 to 11 years; the impact of this recommendation on the lipid clinic setting is unknown. We examined the rate of primary and secondary dyslipidemia diagnoses in a lipid clinic before (2010-2011) and after (2012-2015) the guideline recommendation. We conducted a retrospective study of new clinic patients aged 0 to 20 years seen between April 2010 and April 2015. Chi-square testing was applied. The 345 subjects were 58% males; 48% ≥13 years; 56% Hispanic; and 59% obese. There was no difference in the rate of dyslipidemia diagnoses between periods (before: primary 23%, secondary 73%, no dyslipidemia 4% vs after: 22%, 72%, 6%, respectively; P =.616). There was no significant difference between periods in subject demographics for the total sample, but among those with primary dyslipidemia, pre- to post-guideline percentage of subjects with public insurance decreased (71% to 39%; P =.006). Additional strategies to increase identification of children with dyslipidemia are needed.

Original languageEnglish (US)
Pages (from-to)656-664
Number of pages9
JournalClinical pediatrics
Volume58
Issue number6
DOIs
StatePublished - Jun 1 2019

Fingerprint

Dyslipidemias
Guidelines
Lipids
Insurance
Hispanic Americans
Retrospective Studies
Demography

Keywords

  • cholesterol
  • lipid clinic
  • obesity
  • pediatrics
  • universal screening

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

@article{4cb81ae28c1e4d4ab56fbfff7f564144,
title = "Characteristics of Children Referred to a Lipid Clinic Before and After the Universal Screening Guidelines",
abstract = "In 2011, universal lipid screening was recommended for children aged 9 to 11 years; the impact of this recommendation on the lipid clinic setting is unknown. We examined the rate of primary and secondary dyslipidemia diagnoses in a lipid clinic before (2010-2011) and after (2012-2015) the guideline recommendation. We conducted a retrospective study of new clinic patients aged 0 to 20 years seen between April 2010 and April 2015. Chi-square testing was applied. The 345 subjects were 58{\%} males; 48{\%} ≥13 years; 56{\%} Hispanic; and 59{\%} obese. There was no difference in the rate of dyslipidemia diagnoses between periods (before: primary 23{\%}, secondary 73{\%}, no dyslipidemia 4{\%} vs after: 22{\%}, 72{\%}, 6{\%}, respectively; P =.616). There was no significant difference between periods in subject demographics for the total sample, but among those with primary dyslipidemia, pre- to post-guideline percentage of subjects with public insurance decreased (71{\%} to 39{\%}; P =.006). Additional strategies to increase identification of children with dyslipidemia are needed.",
keywords = "cholesterol, lipid clinic, obesity, pediatrics, universal screening",
author = "Kavitha Selvaraj and Alicia Olave-Pichon and Irwin Benuck and Ariza, {Adolfo Javier} and Helen Binns",
year = "2019",
month = "6",
day = "1",
doi = "10.1177/0009922819834282",
language = "English (US)",
volume = "58",
pages = "656--664",
journal = "Clinical Pediatrics",
issn = "0009-9228",
publisher = "SAGE Publications Inc.",
number = "6",

}

TY - JOUR

T1 - Characteristics of Children Referred to a Lipid Clinic Before and After the Universal Screening Guidelines

AU - Selvaraj, Kavitha

AU - Olave-Pichon, Alicia

AU - Benuck, Irwin

AU - Ariza, Adolfo Javier

AU - Binns, Helen

PY - 2019/6/1

Y1 - 2019/6/1

N2 - In 2011, universal lipid screening was recommended for children aged 9 to 11 years; the impact of this recommendation on the lipid clinic setting is unknown. We examined the rate of primary and secondary dyslipidemia diagnoses in a lipid clinic before (2010-2011) and after (2012-2015) the guideline recommendation. We conducted a retrospective study of new clinic patients aged 0 to 20 years seen between April 2010 and April 2015. Chi-square testing was applied. The 345 subjects were 58% males; 48% ≥13 years; 56% Hispanic; and 59% obese. There was no difference in the rate of dyslipidemia diagnoses between periods (before: primary 23%, secondary 73%, no dyslipidemia 4% vs after: 22%, 72%, 6%, respectively; P =.616). There was no significant difference between periods in subject demographics for the total sample, but among those with primary dyslipidemia, pre- to post-guideline percentage of subjects with public insurance decreased (71% to 39%; P =.006). Additional strategies to increase identification of children with dyslipidemia are needed.

AB - In 2011, universal lipid screening was recommended for children aged 9 to 11 years; the impact of this recommendation on the lipid clinic setting is unknown. We examined the rate of primary and secondary dyslipidemia diagnoses in a lipid clinic before (2010-2011) and after (2012-2015) the guideline recommendation. We conducted a retrospective study of new clinic patients aged 0 to 20 years seen between April 2010 and April 2015. Chi-square testing was applied. The 345 subjects were 58% males; 48% ≥13 years; 56% Hispanic; and 59% obese. There was no difference in the rate of dyslipidemia diagnoses between periods (before: primary 23%, secondary 73%, no dyslipidemia 4% vs after: 22%, 72%, 6%, respectively; P =.616). There was no significant difference between periods in subject demographics for the total sample, but among those with primary dyslipidemia, pre- to post-guideline percentage of subjects with public insurance decreased (71% to 39%; P =.006). Additional strategies to increase identification of children with dyslipidemia are needed.

KW - cholesterol

KW - lipid clinic

KW - obesity

KW - pediatrics

KW - universal screening

UR - http://www.scopus.com/inward/record.url?scp=85062889557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062889557&partnerID=8YFLogxK

U2 - 10.1177/0009922819834282

DO - 10.1177/0009922819834282

M3 - Article

C2 - 30854883

AN - SCOPUS:85062889557

VL - 58

SP - 656

EP - 664

JO - Clinical Pediatrics

JF - Clinical Pediatrics

SN - 0009-9228

IS - 6

ER -